Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma

Clinical and Experimental Allergy

Volumn 43, Issue 9, 2013, Pages 1009-1017

  Seys, S F ^a   Grabowski, M ^a,b   Adriaensen, W ^a   Decraene, A ^a   Dilissen, E ^a   Vanoirbeek, J A ^a,b   Dupont, L J ^a   Ceuppens, J L ^a   Bullens, D M A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Airway inflammation; Asthma control; Asthma phenotyping; Cytokine; Induced sputum

Indexed keywords

CORTICOSTEROID; CYTOKINE; HISTAMINE; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 5; MESSENGER RNA; SALBUTAMOL; STEROID;

ADULT; AGED; AIRWAY; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; IMMUNE FUNCTION TEST; INFLAMMATION; LOW DRUG DOSE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROVOCATION TEST; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPUTUM; SPUTUM ANALYSIS; TH2 CELL;

AIRWAY INFLAMMATION; ASTHMA CONTROL; ASTHMA PHENOTYPING; CYTOKINE; INDUCED SPUTUM;

ADULT; ASTHMA; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; INTERLEUKIN-5; MALE; MIDDLE AGED; RISK FACTORS; SPUTUM; TH2 CELLS; TRANSCRIPTOME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84882796995     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12125     Document Type: Article

References (38)

1. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001; 344:350-62.
2. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368:804-13.
3. Global Initiative for Asthma (GINA). From the Global Strategy for Asthma Management and Prevention, 2012. Available from: http://www.ginasthma.org
4. Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001-8.
5. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875-9.
6. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180:388-95.
7. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008; 38:872-97.
8. Finkelman FD, Hogan SP, Hershey GKK, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010; 184:1663-74.
9. Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy 2006; 91:59-75.
10. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
11. Truyen E, Coteur L, Dilissen E et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006; 61:202-8.
12. + T cells in atopic asthma. Am J Respir Crit Care Med 2005; 171:224-30.
13. Mullings R. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001; 108:832-8.
14. Finotto S, Neurath MF, Glickman JN et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295:336-8.
15. Kumar RK, Webb DC, Herbert C, Foster PS. Interferon-γ as a possible target in chronic asthma. Inflamm Allergy Drug Targets 2006; 5:253-6.
16. Shannon J, Ernst P, Yamauchi Y et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2007; 133:420-6.
17. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118:3546-56.
18. Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol 2009; 123:986-94.
19. Lindén A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25:159-72.
20. Bullens DMA, Truyen E, Coteur L et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135.
21. Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated th17 lymphocytes. J Immunol 2008; 180:7423-30.
22. Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med 2006; 354:697-708.
23. Howarth PH, Babu KS, Arshad HS et al. Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005; 60:1012-8.
24. Wang Y-H, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC activated Th2 memory cells. J Exp Med 2007; 204:1837-47.
25. Wang Y-H, Liu Y-J. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy 2009; 39:798-806.
26. Brasier A, Victor S, Boetticher G et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008; 121(30-37):e6.
27. De Vooght V, Vanoirbeek JAJ, Luyts K, Haenen S, Nemery B, Hoet PHM. Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma. PLoS ONE 2010; 5:e12581.
28. Moro K, Yamada T, Tanabe M et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463:540-4.
29. Saenz SA, Noti M, Artis D. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol 2010; 31:407-13.
30. Wakashin H, Hirose K, Maezawa Y et al. IL-23 and Th17 Cells Enhance Th2-Cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008; 178:1023-32.
31. Wang Y-H, Voo KS, Liu B et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207:2479-91.
32. Rafiq K, Bullens DMA, Kasran A, Lorre K, Ceuppens JL, Van Gool SW. Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines. Clin Exp Immunol 2000; 121:86-93.
33. Upadhyaya B, Yin Y, Hill BJ, Douek DC, Prussin C. Hierarchical IL-5 expression defines a subpopulation of highly differentiated human th2 cells. J Immunol 2011; 187:3111-20.
34. Endo Y, Iwamura C, Kuwahara M et al. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 2011; 35:733-45.
35. + myeloid population that exacerbates asthmatic pathology. Nat Med 2012; 18:751-8.
36. Haldar P, Brightling CE, Hargadon B et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-84.
37. Leckie MJ, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356:2144-8.
38. Schatz M, Sorkness CA, Li JT et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549-56.